Selection between sunitinib and ripretinib using mutation analysis for gastrointestinal stromal tumor patients progressing on imatinib

被引：0
|
作者：
Joensuu, Heikki [1 ,2 ]
机构：
[1] Helsinki Univ Hosp, Dept Oncol, POB 180,Haartmaninkatu 4, Helsinki 00029, Finland
[2] Univ Helsinki, POB 180,Haartmaninkatu 4, Helsinki 00029, Finland
来源：
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY | 2024年 / 9卷
关键词：
Gastrointestinal stromal tumor (GIST); imatinib; sunitinib; ripretinib; PHASE-II TRIAL; KINASE INHIBITOR; EFFICACY; KIT; RESISTANCE; SCHEDULE; MESYLATE; SAFETY;
D O I：
10.21037/tgh-24-32
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Treatment of wild-type gastrointestinal stromal tumor (WT-GIST) with imatinib and sunitinib
    Murray, Matthew
    Hatcher, Helen
    Jessop, Flora
    Williams, Denise
    Carroll, Nicholas
    Bulusu, Ramesh
    Judson, Ian
    PEDIATRIC BLOOD & CANCER, 2008, 50 (02) : 386 - 388
  • [22] Sunitinib for Taiwanese patients with gastrointestinal stromal tumor after imatinib treatment failure or intolerance
    Chen, Yen-Yang
    Yeh, Chun-Nan
    Cheng, Chi-Tung
    Chen, Tsung-Wen
    Rau, Kun-Ming
    Jan, Yi-Yin
    Chen, Miin-Fu
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (16) : 2113 - 2119
  • [23] Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib
    Kang, Y-K
    Yoo, C.
    Ryoo, B-Y
    Lee, J. J.
    Tan, E.
    Park, I.
    Park, J. H.
    Choi, Y. J.
    Jo, J.
    Ryu, J-S
    Ryu, M-H
    BRITISH JOURNAL OF CANCER, 2013, 109 (09) : 2309 - 2315
  • [24] Molecular Target Modulation, Imaging, and Clinical Evaluation of Gastrointestinal Stromal Tumor Patients Treated with Sunitinib Malate after Imatinib Failure
    Demetri, George D.
    Heinrich, Michael C.
    Fletcher, Jonathan A.
    Fletcher, Christopher D. M.
    Van den Abbeele, Annick D.
    Corless, Christopher L.
    Antonescu, Cristina R.
    George, Suzanne
    Morgan, Jeffrey A.
    Chen, Ming Hui
    Bello, Carlo L.
    Huang, Xin
    Cohen, Darrel P.
    Baum, Charles M.
    Maki, Robert G.
    CLINICAL CANCER RESEARCH, 2009, 15 (18) : 5902 - 5909
  • [25] Efficacy and safety of ripretinib vs. sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: A phase 2, multicenter, randomized, open-label study in China
    Li, Jian
    Zhang, Jun
    Zhang, Yanqiao
    Qiu, Haibo
    Zhou, Yanbing
    Zhou, Yongjian
    Zhang, Xinhua
    Zhou, Ye
    Zhu, Yuping
    Li, Yong
    Wang, Ming
    Shen, Kuntang
    Tao, Kaixiong
    Wu, Xin
    Wang, Haijiang
    Zhang, Bo
    Ling, Jiayu
    Ye, Yingjiang
    Wu, Xingye
    Qu, Hongyan
    Ma, Yue
    Jiao, Xuelong
    Zheng, Hualong
    Jin, Jiejie
    Liu, Zhuo
    Tan, Ming
    Fang, Yong
    Zhang, Peng
    Zhang, Nan
    Lei, Cheng
    Cai, Zhaolun
    Liang, Bin
    Peng, Zhangyan
    Huang, Zhao
    Dong, Juan
    Shen, Lin
    EUROPEAN JOURNAL OF CANCER, 2024, 196
  • [26] Phase IV Study of Sunitinib in Chinese Patients with Imatinib-Resistant or Imatinib-Intolerant Gastrointestinal Stromal Tumors
    Lin Shen
    Yan Sun
    Jian-Ming Xu
    Carlos Linn
    Qiao Wang
    Li-Qiang Yang
    Shu-Kui Qin
    Oncology and Therapy, 2017, 5 (2) : 171 - 180
  • [27] Development of a simultaneous quantification method of imatinib and sunitinib and their main metabolites and its application in patients with gastrointestinal stromal tumor
    Chen, Hefen
    Lyu, Jianbo
    Gong, Zhujun
    Han, Yong
    Tao, Kaixiong
    Zhou, Hong
    BIOMEDICAL CHROMATOGRAPHY, 2024, 38 (03)
  • [28] Efficacy of imatinib dose escalation in Chinese gastrointestinal stromal tumor patients
    Li, Jian
    Gong, Ji-Fang
    Li, Jie
    Gao, Jing
    Sun, Nai-Ping
    Shen, Lin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (07) : 698 - 703
  • [29] New findings of kinase switching in gastrointestinal stromal tumor under imatinib using phosphoproteomic analysis
    Takahashi, Tsuyoshi
    Serada, Satoshi
    Ako, Maiko
    Fujimoto, Minoru
    Miyazaki, Yasuaki
    Nakatsuka, Rie
    Ikezoe, Takayuki
    Yokoyama, Akihito
    Taguchi, Takahiro
    Shimada, Kazuki
    Kurokawa, Yukinori
    Yamasaki, Makoto
    Miyata, Hiroshi
    Nakajima, Kiyokazu
    Takiguchi, Shuji
    Mori, Masaki
    Doki, Yuichiro
    Naka, Tetsuji
    Nishida, Toshirou
    INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (11) : 2737 - 2743
  • [30] Effect and safety of ripretinib in the treatment of advanced gastrointestinal stromal tumor: A systematic review and meta-analysis
    Li, Ji
    Zhang, Hao
    Chen, Xiao-Dong
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2024, 15 (08):
12345